Free Trial

Neurogene (NGNE) News Today

Neurogene logo
$13.05 -2.06 (-13.63%)
Closing price 04:00 PM Eastern
Extended Trading
$13.20 +0.15 (+1.15%)
As of 06:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Neurogene Inc. stock logo
Baker BROS. Advisors LP Boosts Holdings in Neurogene Inc. (NASDAQ:NGNE)
Baker BROS. Advisors LP grew its position in shares of Neurogene Inc. (NASDAQ:NGNE - Free Report) by 47.9% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 674,450 shares of the company's stock after buying an additional 218,435 shares durin
Neurogene Inc. stock logo
ArrowMark Colorado Holdings LLC Has $10.26 Million Stock Position in Neurogene Inc. (NASDAQ:NGNE)
ArrowMark Colorado Holdings LLC grew its position in shares of Neurogene Inc. (NASDAQ:NGNE - Free Report) by 16.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 448,601 shares of the company's stock after acquiring a
Neurogene Inc. stock logo
Neurogene (NGNE) Expected to Announce Earnings on Friday
Neurogene (NASDAQ:NGNE) will be releasing its Q1 2025 earnings before the market opens on Friday, May 9. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-9-neurogene-inc-stock/)
Neurogene Inc. stock logo
Samsara BioCapital LLC Acquires 449,337 Shares of Neurogene Inc. (NASDAQ:NGNE)
Samsara BioCapital LLC lifted its stake in shares of Neurogene Inc. (NASDAQ:NGNE - Free Report) by 35.4% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,717,127 shares of the company's stock after buying an additional 449,337 shares
Neurogene Inc. stock logo
Rock Springs Capital Management LP Invests $2.18 Million in Neurogene Inc. (NASDAQ:NGNE)
Rock Springs Capital Management LP bought a new position in shares of Neurogene Inc. (NASDAQ:NGNE - Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 95,407 shares of the company's stock, val
Neurogene Inc. stock logo
Neurogene Inc. (NASDAQ:NGNE) Shares Bought by Walleye Capital LLC
Walleye Capital LLC grew its position in Neurogene Inc. (NASDAQ:NGNE - Free Report) by 68.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 74,836 shares of the company's stock after buying an additi
Neurogene Inc. stock logo
Neurogene Inc. (NASDAQ:NGNE) Given Average Rating of "Buy" by Brokerages
Shares of Neurogene Inc. (NASDAQ:NGNE - Get Free Report) have been given a consensus recommendation of "Buy" by the eight analysts that are presently covering the company, Marketbeat reports. Seven investment analysts have rated the stock with a buy rating and one has issued a strong buy rating o
Neurogene Inc. stock logo
BMO Capital Markets Has Lowered Expectations for Neurogene (NASDAQ:NGNE) Stock Price
BMO Capital Markets dropped their target price on Neurogene from $45.00 to $16.00 and set an "outperform" rating on the stock in a research report on Monday.
Neurogene Inc. stock logo
JPMorgan Chase & Co. Purchases 476,418 Shares of Neurogene Inc. (NASDAQ:NGNE)
JPMorgan Chase & Co. grew its holdings in shares of Neurogene Inc. (NASDAQ:NGNE - Free Report) by 10,395.3% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 481,001 shares of the company's stock after purchasing an addition
Neurogene price target lowered to $16 from $45 at BMO Capital
Neurogene Inc. stock logo
62,640 Shares in Neurogene Inc. (NASDAQ:NGNE) Bought by Blair William & Co. IL
Blair William & Co. IL acquired a new stake in shares of Neurogene Inc. (NASDAQ:NGNE - Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The fund acquired 62,640 shares of the company's stock, valued at approximately $1,432,000. Blair William & Co. IL owned
Neurogene Inc. stock logo
What is HC Wainwright's Forecast for Neurogene Q1 Earnings?
Neurogene Inc. (NASDAQ:NGNE - Free Report) - Stock analysts at HC Wainwright issued their Q1 2025 earnings per share estimates for shares of Neurogene in a research note issued on Tuesday, March 25th. HC Wainwright analyst M. Kapoor forecasts that the company will post earnings of ($0.85) per sha
Neurogene Inc. stock logo
Q1 Earnings Estimate for Neurogene Issued By Leerink Partnrs
Neurogene Inc. (NASDAQ:NGNE - Free Report) - Analysts at Leerink Partnrs issued their Q1 2025 earnings per share (EPS) estimates for shares of Neurogene in a research note issued to investors on Monday, March 24th. Leerink Partnrs analyst M. Foroohar expects that the company will earn ($1.12) per
Neurogene Inc. stock logo
What is William Blair's Estimate for Neurogene Q1 Earnings?
Neurogene Inc. (NASDAQ:NGNE - Free Report) - Stock analysts at William Blair issued their Q1 2025 EPS estimates for shares of Neurogene in a research report issued on Tuesday, March 25th. William Blair analyst S. Corwin expects that the company will post earnings of ($0.92) per share for the quar
Neurogene Inc. stock logo
Q1 Earnings Estimate for Neurogene Issued By William Blair
Neurogene Inc. (NASDAQ:NGNE - Free Report) - William Blair issued their Q1 2026 earnings estimates for Neurogene in a note issued to investors on Tuesday, March 25th. William Blair analyst S. Corwin anticipates that the company will post earnings of ($1.18) per share for the quarter. William Blai
Neurogene Inc. stock logo
William Blair Reiterates "Outperform" Rating for Neurogene (NASDAQ:NGNE)
William Blair reiterated an "outperform" rating on shares of Neurogene in a research report on Tuesday.
Neurogene Inc. stock logo
Neurogene Inc. (NASDAQ:NGNE) Given Consensus Recommendation of "Buy" by Brokerages
Shares of Neurogene Inc. (NASDAQ:NGNE - Get Free Report) have earned a consensus rating of "Buy" from the eight brokerages that are covering the stock, MarketBeat reports. Seven analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average 1
Neurogene price target lowered to $38 from $46 at Baird
Neurogene price target lowered to $50 from $55 at H.C. Wainwright
Neurogene Inc. stock logo
Neurogene (NASDAQ:NGNE) Price Target Cut to $50.00 by Analysts at HC Wainwright
HC Wainwright dropped their price objective on shares of Neurogene from $55.00 to $50.00 and set a "buy" rating for the company in a report on Tuesday.
Neurogene Inc. stock logo
Neurogene (NASDAQ:NGNE) Issues Quarterly Earnings Results
Neurogene (NASDAQ:NGNE - Get Free Report) released its quarterly earnings results on Monday. The company reported ($0.99) earnings per share for the quarter, topping the consensus estimate of ($1.04) by $0.05.
Neurogene Inc. stock logo
Neurogene (NASDAQ:NGNE) Posts Quarterly Earnings Results, Beats Expectations By $0.05 EPS
Neurogene (NASDAQ:NGNE - Get Free Report) announced its earnings results on Monday. The company reported ($0.99) earnings per share for the quarter, beating analysts' consensus estimates of ($1.04) by $0.05.
Neurogene Inc. stock logo
Christine Mikail Cvijic Sells 4,501 Shares of Neurogene Inc. (NASDAQ:NGNE) Stock
Neurogene Inc. (NASDAQ:NGNE - Get Free Report) CFO Christine Mikail Cvijic sold 4,501 shares of the firm's stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $16.94, for a total transaction of $76,246.94. Following the sale, the chief financial officer now owns 72,343 shares of the company's stock, valued at approximately $1,225,490.42. The trade was a 5.86 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.
Neurogene Inc. stock logo
Neurogene Inc. (NASDAQ:NGNE) Short Interest Update
Neurogene Inc. (NASDAQ:NGNE - Get Free Report) saw a large decline in short interest in February. As of February 15th, there was short interest totalling 1,750,000 shares, a decline of 12.9% from the January 31st total of 2,010,000 shares. Approximately 10.1% of the company's shares are short sold. Based on an average trading volume of 321,600 shares, the days-to-cover ratio is presently 5.4 days.
Neurogene Inc. stock logo
Neurogene (NASDAQ:NGNE) Shares Down 8.4% - Here's Why
Neurogene (NASDAQ:NGNE) Shares Down 8.4% - Here's What Happened
Neurogene Insiders Placed Bullish Bets Worth US$1.46m
Neurogene Inc. stock logo
Neurogene (NGNE) Projected to Post Quarterly Earnings on Monday
Neurogene (NASDAQ:NGNE) will be releasing earnings before the market opens on Monday, February 17, Financial Modeling Prep reports.
Neurogene Inc. stock logo
Neurogene Inc. (NASDAQ:NGNE) Receives Consensus Rating of "Buy" from Brokerages
Shares of Neurogene Inc. (NASDAQ:NGNE - Get Free Report) have earned an average rating of "Buy" from the eight analysts that are covering the company, MarketBeat reports. Seven analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. Th
Neurogene Inc. (NGNE)
Neurogene Inc. stock logo
Neurogene Inc. (NASDAQ:NGNE) Given Consensus Recommendation of "Buy" by Analysts
Neurogene Inc. (NASDAQ:NGNE - Get Free Report) has been assigned an average rating of "Buy" from the eight brokerages that are presently covering the firm, Marketbeat Ratings reports. Seven analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. T
Get Neurogene News Delivered to You Automatically

Sign up to receive the latest news and ratings for NGNE and its competitors with MarketBeat's FREE daily newsletter.

NGNE Media Mentions By Week

NGNE Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

NGNE
News Sentiment

1.42

0.69

Average
Medical
News Sentiment

NGNE News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

NGNE Articles
This Week

4

3

NGNE Articles
Average Week

Get Neurogene News Delivered to You Automatically

Sign up to receive the latest news and ratings for NGNE and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:NGNE) was last updated on 5/6/2025 by MarketBeat.com Staff
From Our Partners